Loading stock data…
Loading stock data…
US$0.00
Get one email when CNBX crosses your level. Checked every 15 minutes during market hours.
▲ +0.00 (0.00%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.0
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.00
Bearish momentumMACD below its signal line (-0.00).
50-day average
0.00
Price belowShort-term trend reference.
200-day average
0.00
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Cnbx Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of cannabinoid-based therapies. The primary focus of the company is leveraging cannabis compounds to create innovative treatments for a range of medical conditions. With the rise of medical cannabis, Cnbx Pharmaceuticals seeks to explore the benefits of cannabinoids, working on formulations that target specific illnesses, including cancer and neurological disorders. Noteworthy in the healt…
www.cnbxpharma.com| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-22 | 1.34 | 1.78 | ✓ Beat |
Companies in the same industry, via Finnhub